Study of the Effect of Diabetes on the Incidence and the Extent of Coronary Artery Disease

University of Ioannina1,104 enrolled

Overview

In the present study the investigators will measure the extent of coronary artery disease via coronary angiography and the correlating risk factors.

In the present study the investigators will examine the risk factors determining the development, extent and the manifestation of coronary artery disease. The study will recruit patients undergoing coronary angiography for clinical purposes.

Study Type

OBSERVATIONAL

Enrollment

1,104

Conditions

Patients Undergoing Coronary Angiography

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Any subject eligible for coronary angiography with or without known CV disease for clinical reasons. Exclusion Criteria: * Patients revascularized in the past, with either coronary artery bypass grafting or percutaneous coronary intervention, will be excluded from the study since it is not possible to describe the extent of CAD in these patients. * Moderate or severe aortic stenosis.

Locations (1)

2nd Department of Cardiology, University Hospital of Ioannina

Ioannina, Greece

Outcomes

Primary Outcomes

The incidence and extent of coronary artery disease between diabetics and non-diabetic patients.

We will investigate the incidence, extent and clinical manifestation of coronary artery disease in diabetics and non-diabetics undergoing coronary angiography for clinical reasons.

Time frame: Up to four years on average.

Secondary Outcomes

The incidence and extent of coronary artery disease via coronary angiography scores and related biochemical and demographical risk factors.

To associate the incidence, extent and clinical manifestation of coronary artery disease with classic demographic risk factors (such as smoking, alcohol consumption, physical exercise, arterial hypertension, family history of diabetes mellitus or coronary artery disease) and common biochemical risk factors (such as fasting glucose levels, urea, creatinine, HbA1c%, uric acid, total cholesterol, HDL, LDL, triglycerides, VLDL, glomerular filtration rate - GFR).

Time frame: Up to 4 years on average.

The incidence, extent and clinical manifestation of coronary artery disease and the circulating levels of hs-CRP, adipokines and RAGEs.

To associate the incidence, extent and clinical manifestation of coronary artery disease with systemic inflammatory status assessed by hs-CRP levels, circulating adipokines (adiponectin, resistin) and the receptors of advanced glycation end products (sRAGE and esRAGE).

Time frame: Up to 4 years on average.

TCF7L2 gene polymorphims and the incidence and extent of coronary artery disease.

To associate the incidence, extent and clinical manifestation of coronary artery disease with the rs7903146 single nucleotide polymorphism of TCF7L2 gene, that has been strongly associated with diabetes mellitus development.

Time frame: Within a maximum period of 4 years.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.